AAV gene therapy (Taysha Gene Therapies/University of Texas Southwestern Medical Center)

N/A

Report date: 2025/03/14 16:43:35

Base Information

Drug NameAAV gene therapy (Taysha Gene Therapies/University of Texas Southwestern Medical Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGenetic Diseases, InbornEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaysha Gene Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical CenterTaysha Gene Therapies Inc
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, InbornEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A